Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | HMG-CoA reductase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0339 | 0.2022 | 0.3206 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.0165 | 0.0132 | 0.021 |
Echinococcus multilocularis | proteasome (prosome, macropain) subunit, beta | 0.0307 | 0.1681 | 0.2909 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.107 | 1 | 1 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0165 | 0.0132 | 0.0229 |
Schistosoma mansoni | hypothetical protein | 0.0339 | 0.2022 | 0.3206 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0165 | 0.0132 | 0.0229 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0683 | 0.5781 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0339 | 0.2022 | 0.2022 |
Brugia malayi | Hydroxymethylglutaryl-coenzyme A reductase family protein | 0.0165 | 0.0132 | 0.0132 |
Leishmania major | proteasome beta 2 subunit, putative | 0.0307 | 0.1681 | 0.2909 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0683 | 0.5781 | 1 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0683 | 0.5781 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.107 | 1 | 1 |
Schistosoma mansoni | proteasome subunit beta 2 (T01 family) | 0.0307 | 0.1681 | 0.2666 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0683 | 0.5781 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0731 | 0.6307 | 0.6307 |
Loa Loa (eye worm) | proteasome subunit beta type 2 | 0.0307 | 0.1681 | 0.1681 |
Toxoplasma gondii | proteasome subunit beta type 2, putative | 0.0307 | 0.1681 | 0.2909 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0683 | 0.5781 | 0.5781 |
Trypanosoma cruzi | 20S proteasome subunit | 0.0307 | 0.1681 | 0.2909 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0339 | 0.2022 | 0.2022 |
Plasmodium falciparum | proteasome subunit beta type-2, putative | 0.0307 | 0.1681 | 0.2909 |
Loa Loa (eye worm) | hypothetical protein | 0.0731 | 0.6307 | 0.6307 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0683 | 0.5781 | 0.5781 |
Schistosoma mansoni | proteasome subunit beta 2 (T01 family) | 0.0307 | 0.1681 | 0.2666 |
Echinococcus multilocularis | GPCR, family 2 | 0.0339 | 0.2022 | 0.3498 |
Schistosoma mansoni | hypothetical protein | 0.0731 | 0.6307 | 1 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0683 | 0.5781 | 1 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.0165 | 0.0132 | 0.0229 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0339 | 0.2022 | 0.3498 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0683 | 0.5781 | 1 |
Mycobacterium ulcerans | proteasome PrcB | 0.0683 | 0.5781 | 1 |
Echinococcus granulosus | proteasome prosome macropain | 0.0683 | 0.5781 | 1 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0165 | 0.0132 | 0.0229 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0683 | 0.5781 | 1 |
Giardia lamblia | Proteasome subunit beta type 2 | 0.0307 | 0.1681 | 0.2909 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0339 | 0.2022 | 0.2022 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0683 | 0.5781 | 0.9165 |
Echinococcus granulosus | GPCR family 2 | 0.0339 | 0.2022 | 0.3498 |
Entamoeba histolytica | probable proteasome subunit beta type 2, putative | 0.0307 | 0.1681 | 0.2909 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0165 | 0.0132 | 0.0229 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0683 | 0.5781 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0339 | 0.2022 | 0.3206 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0683 | 0.5781 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0339 | 0.2022 | 0.2022 |
Loa Loa (eye worm) | hypothetical protein | 0.0165 | 0.0132 | 0.0132 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0307 | 0.1681 | 0.2909 |
Trypanosoma cruzi | proteasome subunit beta type-2, putative | 0.0307 | 0.1681 | 0.2909 |
Echinococcus granulosus | proteasome prosome macropain subunit beta | 0.0307 | 0.1681 | 0.2909 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0307 | 0.1681 | 0.2909 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.107 | 1 | 1 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0683 | 0.5781 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0339 | 0.2022 | 0.3206 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.0165 | 0.0132 | 0.0229 |
Brugia malayi | proteasome subunit beta type 2 | 0.0307 | 0.1681 | 0.1681 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0683 | 0.5781 | 1 |
Plasmodium vivax | proteasome subunit beta type-2, putative | 0.0307 | 0.1681 | 0.2909 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0683 | 0.5781 | 0.5 |
Trypanosoma brucei | proteasome subunit beta type-2, putative | 0.0307 | 0.1681 | 0.2909 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0339 | 0.2022 | 0.3498 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0683 | 0.5781 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0339 | 0.2022 | 0.3498 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0339 | 0.2022 | 0.3498 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.